PepVault
/ database / GLP-1 / Glucagon Dual

Efinopegdutide

Also: MK-6024

GLP-1/glucagon agonist studied primarily for fatty liver disease.

Evidence
emerging
Legal status
research only
Half-life
Long (days+)
Routes
subq
View on Limitless LifeAdd to compare
What it is

GLP-1/glucagon agonist studied primarily for fatty liver disease.

Mechanism

GLP-1/glucagon agonist studied primarily for fatty liver disease.

Outcomes it's matched to
Safety

Educational reference only. Long-term human safety varies; consult a peptide-literate clinician.

Legal context

Investigational

1:1 GUIDANCE

Have questions about this peptide?

Get free 1:1 guidance from a peptide professional before you start. They'll help you think through dosing, stacking, and whether this fits your goals.

REQUEST A CALL →
PepVault

An outcome-driven reference for modern peptides. Educational only — not medical advice, not a sales platform, not affiliated with any clinic.

Disclaimer: PepVault is an educational resource. Nothing on this site is medical advice. Many peptides discussed are research compounds and are not approved by the FDA or equivalent agencies. Always consult a qualified clinician before starting any protocol.

© 2026 PepVault